Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) … [Read more...] about Boston Scientific throws in the towel on Lotus TAVR
Boston Scientific
Boston Scientific warns on Hurricane RX biliary balloon dilatation catheter
Boston Scientific (NYSE:BSX) said it is recalling specific lots/batches of its Hurricane RX biliary balloon dilation catheters. Marlborough, Mass.-based Boston Scientific, which issued a warning letter from its international location in France, said the removal comes in response to an increase in complaints of the RX tunnel component (black … [Read more...] about Boston Scientific warns on Hurricane RX biliary balloon dilatation catheter
How fish physiology is enabling Boston Scientific to help atrial fibrillation patients
Company researchers developed cardiac ablation technology that mimics the navigation system of electric fish. Scientists have studied electric fish for decades to determine how and why they discharge electricity. Recently, a couple of biomedical engineers at Boston Scientific realized that the way these fish use their electrical impulses … [Read more...] about How fish physiology is enabling Boston Scientific to help atrial fibrillation patients
Boston Scientific launches DirectSense technology
Boston Scientific (NYSE:BSX) announced today that it launched its DirectSense for monitoring the effect of radiofrequency (RF) energy during cardiac ablation procedures. Marlborough, Mass.-based Boston Scientific’s DirectSense is available on the Rhythmia HDx mapping system that won FDA approval in April. Rhythmia HDx monitors changes in local … [Read more...] about Boston Scientific launches DirectSense technology
Boston Scientific has a Class I recall of angiographic catheters
The FDA has issued a Class I designation for a recall involving the Imager II 5F angiographic catheters produced by Boston Scientific (NYSE:BSX). Marlborough, Mass.-based Boston Scientific’s catheters are designed to provide a pathway for delivering contrast agents to blood vessels including carotid arteries. Get the full story at our sister … [Read more...] about Boston Scientific has a Class I recall of angiographic catheters
Study: Boston Sci’s Watchman cheaper than drugs long-term
A new study has found that use of the Boston Scientific (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device to treat atrial fibrillation costs less than existing and novel anticoagulant drugs over five years. The retrospective study pooled data from the randomized trials of the Marlborough, Mass.-based company’s Watchman device. The … [Read more...] about Study: Boston Sci’s Watchman cheaper than drugs long-term
